Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

about

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

Item

http://www.wikidata.org/entity/Q58580934

description

article

@en

wetenschappelijk artikel

@nl

name

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

@en

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

@nl

type

Item

label

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

@en

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

@nl

prefLabel

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

@en

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

@nl

P1476

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

@en

P2093

Adrian Javaherian

http://www.w3.org/2001/XMLSchema#string

Edan Itzkovitz

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for prevention of herpes simplex labialis (cold sores on the lips)

Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients

Acyclovir in recurrent herpes labialis

3-Econsystems: MicroRNAs, Receptors, and Latent Viruses; Some Insights Biology Can Gain from Economic Theory

Human herpes simplex virus: life cycle and development of inhibitors

Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis

The retrospective chart review: important methodological considerations.

Help-seeking behaviour among people living with chronic hip or knee pain in the community.

Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study.

Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and

P304

2515690X18806269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2515690X18806269

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hanan Polansky

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30362389

http://www.w3.org/2001/XMLSchema#string

P932

6204621

http://www.w3.org/2001/XMLSchema#string